Search Results - "BIJISMA, Johannes W. J"

Alendronate or Alfacalcidol in Glucocorticoid-Induced Osteoporosis by de Nijs, Ron N.J, Jacobs, Johannes W.G, Lems, Willem F, Laan, Roland F.J, Algra, Ale, Huisman, Anne-Margriet, Buskens, Erik, de Laet, Chris E.D, Oostveen, Ans C.M, Geusens, Piet P.M.M, Bruyn, George A.W, Dijkmans, Ben A.C, Bijlsma, Johannes W.J

“…In this clinical trial, patients who had a rheumatic disease and were receiving glucocorticoids were given either daily alendronate and alfacalcidol placebo or…”
Get full text

Adalimumab alone and in combination with disease-modifying antirheumatic t drugs for the treatment of rheumatoid arthritis in clinical practice : the Research in Active Rheumatoid Arthritis (ReAct) trial by BURMESTER, Gerd R, MARIETTE, Xavier, MONTECUCCO, Carlomaurizio, MONTEAGUDO-SAEZ, Indalecio, MALAISE, Michel, TZIOUFAS, Athanasios G, BIJISMA, Johannes W. J, UNNEBRINK, Kristina, KARY, Sonja, KUPPER, Hartmut

Get full text

Proinflammatory mediator–induced reversal of CD4+,CD25+ regulatory T cell–mediated suppression in rheumatoid arthritis by van Amelsfort, Jocea M. R., van Roon, Joel A. G., Noordegraaf, Madelon, Jacobs, Kim M. G., Bijlsma, Johannes W. J., Lafeber, Floris P. J. G., Taams, Leonie S.

“…Objective We previously demonstrated that CD4+,CD25+ regulatory T (Treg) cells are present in increased numbers in the synovial fluid (SF) of rheumatoid…”
Get full text

The combination of the biomarkers urinary C‐terminal telopeptide of type II collagen, serum cartilage oligomeric matrix protein, and serum chondroitin sulfate 846 reflects cartilage damage in hemophilic arthropathy by Jansen, Nathalie W. D., Roosendaal, Goris, Lundin, Björn, Heijnen, Lily, Mauser‐Bunschoten, Evelien, Bijlsma, Johannes W. J., Theobald, Matthias, Lafeber, Floris P. J. G.

“…Objective Hemophilic arthropathy, with characteristics of inflammatory (rheumatoid arthritis) and degenerative (osteoarthritis) joint damage, occurs at an…”
Get full text

Followup radiographic data on patients with rheumatoid arthritis who participated in a two‐year trial of prednisone therapy or placebo by Jacobs, Johannes W. G., Everdingen, Amalia A. Van, Verstappen, Suzan M. M., Bijlsma, Johannes W. J.

“…Objective In a previous clinical trial of patients with early rheumatoid arthritis (RA), it was determined that patients who received 10 mg of prednisone per…”
Get full text